July 23 (Reuters) - Radius Health Inc RDUS.O :
* MENARINI GROUP AND RADIUS HEALTH ANNOUNCE GLOBAL LICENSE AGREEMENT FOR THE DEVELOPMENT AND COMMERCIALIZATION OF ELACESTRANT
* MENARINI GROUP - CO WILL BE RESPONSIBLE FOR WORLDWIDE COMMERCIALIZATION OF ELACESTRANT IN AGREEMENT
* MENARINI GROUP - RADIUS WILL RECEIVE AN UPFRONT PAYMENT OF $30 MILLION AND UP TO $320 MILLION IN ADDITIONAL PAYMENTS IN AGREEMENT